Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Eitzman

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Arthritis and Rheumatism|May 3, 2012
Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisSeth G Thacker, Wenpu Zhao, Carolyne K Smith, et al.
Journal of the American Heart Association|September 17, 2020
Diversity, Equity, and Inclusiveness in Medicine and Cardiology: Next Steps for <i>JAHA</i>Barry London, Ferhaan Ahmad, Daniel T Eitzman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 2005
Atherosclerosis in mice is not affected by a reduction in tissue factor expressionRachel E Tilley, Brian Pedersen, Rafal Pawlinski, et al.
JCI Insight|September 22, 2017
Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic targetJason S Knight, He Meng, Patrick Coit, et al.
British Journal of Pharmacology|October 5, 2024
The first in-human study to evaluate the antiplatelet properties of the clopidogrel conjugate DT-678 in acute coronary syndrome patients and healthy volunteersZhihao Liu, Shengcong Liu, Yanjun Gong, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Arthritis and Rheumatism|May 3, 2012
Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisSeth G Thacker, Wenpu Zhao, Carolyne K Smith, et al.
Journal of the American Heart Association|September 17, 2020
Diversity, Equity, and Inclusiveness in Medicine and Cardiology: Next Steps for <i>JAHA</i>Barry London, Ferhaan Ahmad, Daniel T Eitzman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 2005
Atherosclerosis in mice is not affected by a reduction in tissue factor expressionRachel E Tilley, Brian Pedersen, Rafal Pawlinski, et al.
JCI Insight|September 22, 2017
Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic targetJason S Knight, He Meng, Patrick Coit, et al.
British Journal of Pharmacology|October 5, 2024
The first in-human study to evaluate the antiplatelet properties of the clopidogrel conjugate DT-678 in acute coronary syndrome patients and healthy volunteersZhihao Liu, Shengcong Liu, Yanjun Gong, et al.
Pageof 7